Yewande Odeyemi, M.B.B.S.

Open

• A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections Rochester, Minn.

  The purpose of this study is to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. 

• Individualizing Corticosteroid Use in Pneumonia Rochester, Minn.

  The objectives of this study are to identify predictors of in-hospital disease progression (prognostic enrichment), to develop an individualized treatment rule (ITR) for steroid use through advanced statistical and machine learning methods (predictive enrichment), and to evaluate an ITR-guided corticosteroid use coupled with biomarker-guided dosing strategy (optimal patient selection and dosing) in community acquired pneumonia (CAP).